| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Transplacental Toxicology Section, Laboratory of Reproductive and Developmental Toxicology, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, North Carolina 27709
The association of intrauterine exposure to diethylstilbestrol (DES) and the subsequent development of reproductive tract abnormalities in young women has been well documented. Although the incidence of vaginal adenocarcinoma was low in the exposed population, vaginal adenosis, a nonmalignant abnormality, was quite common. In order to study the pathogenesis of adenocarcinoma and to determine the frequency of adenosis following prenatal exposure to DES, timed pregnant CD-1 mice were treated s.c. with DES (dose range, 5 to 100 µg/kg/day) on Days 9 through 16 of gestation. This period corresponds to major organogenesis of the reproductive tract in the mouse. Female offspring were sacrificed between 1 and 18 months of age. In addition to nonmalignant abnormalities, some of which have been described in women exposed prenatally to DES, two cases of vaginal adenocarcinoma (2%) were observed in 91 prenatally DES-treated animals. No comparable epithelial lesions were seen in 158 control female mice. One other case of adenocarcinoma of the vagina was reported previously by this laboratory using the prenatally exposed animal model.
In another series of mice treated prenatally with DES, 100 µg/kg/day, 3 of 20 (15%) 1-month-old animals and one of 10 (10%) 18-month-old treated offspring had glandular epithelium abnormally located in the vaginal fornices (adenosis). Other cervicovaginal abnormalities observed after prenatal DES exposure included structural alterations, cervical enlargement, squamous metaplasia in the endocervical canal, excess keratinization of the ectocervix and vagina, transverse folds and basal cell hyperplasia in the upper vagina, and prominent Wolffian duct remnants. Thus, vaginal adenosis in the mouse does not appear to be a common abnormality following treatment with DES in utero. Neonatal exposure to DES on Days 1 to 5, on the other hand, resulted in six of eight (75%) animals with adenosis at 35 days of age. Since perinatal mouse studies have reported high incidences of vaginal adenosis but, to our knowledge, no cases of vaginal adenocarcinoma, the results presented in this report suggest that the stage of cellular differentiation at the time of DES exposure may be critical in the final expression of these abnormalities.
1 To whom requests for reprints should be addressed.
Received 3/25/81. Accepted 2/ 8/82.
This article has been cited by other articles:
|
|
 |
|
  S. A. Vogel The Politics of Plastics: The Making and Unmaking of Bisphenol A "Safety" Am J Public Health, November 1, 2009; 99(S3): S559 - S566. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yin, W.-W. Huang, C. Lin, H. Chen, A. MacKenzie, and L. Ma Estrogen Suppresses Uterine Epithelial Apoptosis by Inducing Birc1 Expression Mol. Endocrinol., January 1, 2008; 22(1): 113 - 125. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Titus-Ernstoff, R. Troisi, E. E Hatch, L. A Wise, J. Palmer, M. Hyer, R. Kaufman, E. Adam, W. Strohsnitter, K. Noller, et al. Menstrual and reproductive characteristics of women whose mothers were exposed in utero to diethylstilbestrol (DES) Int. J. Epidemiol., August 1, 2006; 35(4): 862 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Yin, C. Lin, and L. Ma Msx2 Promotes Vaginal Epithelial Differentiation and Wolffian Duct Regression and Dampens the Vaginal Response to Diethylstilbestrol Mol. Endocrinol., July 1, 2006; 20(7): 1535 - 1546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. V. Henley and K. S. Korach Endocrine-Disrupting Chemicals Use Distinct Mechanisms of Action to Modulate Endocrine System Function Endocrinology, June 1, 2006; 147(6): s25 - s32. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Suzuki, H. Watanabe, T. Mizutani, T. Sato, Y. Ohta, and T. Iguchi Global Gene Expression in Mouse Vaginae Exposed to Diethylstilbestrol at Different Ages. Experimental Biology and Medicine, May 1, 2006; 231(5): 632 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. McAnulty and M. Skydsgaard Diethylstilbestrol (DES): Carcinogenic Potential in Xpa-/-, Xpa-/-/p53+/-, and Wild-Type Mice During 9 Months' Dietary Exposure Toxicol Pathol, August 1, 2005; 33(5): 609 - 620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Yin and L. Ma Development of the Mammalian Female Reproductive Tract J. Biochem., June 1, 2005; 137(6): 677 - 683. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Tong, L. K. Christenson, and W.-C. Song Aberrant Cholesterol Transport and Impaired Steroidogenesis in Leydig Cells Lacking Estrogen Sulfotransferase Endocrinology, May 1, 2004; 145(5): 2487 - 2497. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. J. Hendry III, W. S. Branham, and D. M. Sheehan Diethylstilbestrol Versus Estradiol as Neonatal Disruptors of the Hamster (Mesocricetus auratus) Cervix Biol Reprod, May 1, 2004; 70(5): 1306 - 1316. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Katsu, D. B. Lubahn, and T. Iguchi Expression of a Novel C-Type Lectin in the Mouse Vagina Endocrinology, June 1, 2003; 144(6): 2597 - 2605. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Hendry III, D. M. Sheehan, S. A. Khan, and J. V. May Developing a Laboratory Animal Model for Perinatal Endocrine Disruption: The Hamster Chronicles Experimental Biology and Medicine, October 1, 2002; 227(9): 709 - 723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Newbold, A. B. Moore, and D. Dixon Characterization of Uterine Leiomyomas in CD-1 Mice Following Developmental Exposure to Diethylstilbestrol (DES) Toxicol Pathol, August 1, 2002; 30(5): 611 - 616. [Abstract] [PDF]
|
|
|
|
 |
|
 J. Odum, P. A. Lefevre, H. Tinwell, J. P. Van Miller, R. L. Joiner, R. E. Chapin, N. T. Wallis, and J. Ashby Comparison of the Developmental and Reproductive Toxicity of Diethylstilbestrol Administered to Rats in Utero, Lactationally, Preweaning, or Postweaning Toxicol. Sci., July 1, 2002; 68(1): 147 - 163. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yoshida, A. Takenaka, S.-I. Katsuda, Y. Kurokawa, and A. Maekawa Neonatal Exposure to p-tert-octylphenol Causes Abnormal Expression of Estrogen Receptor {alpha} and Subsequent Alteration of Cell Proliferating Activity in the Developing Donryu Rat Uterus Toxicol Pathol, April 1, 2002; 30(3): 357 - 364. [Abstract] [PDF]
|
|
|
|
|
|
D. M. Klotz, S. C. Hewitt, K. S. Korach, and R. P. Diaugustine Activation of a Uterine Insulin-Like Growth Factor I Signaling Pathway by Clinical and Environmental Estrogens: Requirement of Estrogen Receptor-{alpha} Endocrinology, September 1, 2000; 141(9): 3430 - 3439. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. K. Dienhart, R. J. Sommer, R. E. Peterson, A. N. Hirshfield, and E. K. Silbergeld Gestational Exposure to 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Developmental Defects in the Rat Vagina Toxicol. Sci., July 1, 2000; 56(1): 141 - 149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Newbold, R. B. Hanson, W. N. Jefferson, B. C. Bullock, J. Haseman, and J. A. McLachlan Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol Carcinogenesis, July 1, 2000; 21(7): 1355 - 1363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Carthew, R. E. Edwards, B. M. Nolan, E. A. Martin, R. T. Heydon, I. N.H. White, and M. J. Tucker Tamoxifen induces endometrial and vaginal cancer in rats in the absence of endometrial hyperplasia Carcinogenesis, April 1, 2000; 21(4): 793 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Hendry III, B. L. DeBrot, X. Zheng, W. S. Branham, and D. M. Sheehan Differential Activity of Diethylstilbestrol versus Estradiol As Neonatal Endocrine Disruptors in the Female Hamster (Mesocricetus auratus) Reproductive Tract Biol Reprod, July 1, 1999; 61(1): 91 - 100. [Abstract] [Full Text]
|
|
|
|
 |
|
 K. Korach Insights from the study of animals lacking functional estrogen receptor Science, December 2, 1994; 266(5190): 1524 - 1527. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
